Vermont Governor Signs Drug Price Transparency Bill
On Friday, June 3, 2016, Vermont Governor Peter Shumlin signed into law a bill that aims to require greater transparency on behalf…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Shatterproof Report on Critical Elements of Effective State Opioid…
The opioid epidemic has been a prominent talking point in many circles lately, including physician groups, Congress,…
FDA Announces Information Collection Regarding Biosimilar Suffixes
The Food and Drug Administration (FDA) has announced an information collection seeking sponsors of past and present…
Massachusetts Cost Trend Report and Suggestions
Massachusetts is required to release annual Cost Trend reports that make recommendations and commitments to advance…
DOJ Announces Genentech and OSI Pharmaceuticals, LLC Settlement
The Department of Justice (DOJ) has announced that pharmaceutical companies Genentech and OSI Pharmaceuticals, LLC, will…
Jazz Pharmaceuticals Discloses DOJ Subpoena on Patient Assistance Program
Jazz Pharmaceuticals recently revealed, in a filing with the Securities and Exchange Commission, that it received a…
House Energy and Commerce Ask FDA for Update on Off Label Guidance
The House of Representatives, through the Energy and Commerce Committee, are questioning the United States Food and Drug…
Presidential Advisory Council on Combating Antibiotic Resistant Bacteria…
The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria ("Advisory Council") has issued a Request…
Using Massachusetts Physician Payment Data Prescribing Patterns Under…
Prescribing practices of physicians are once again under attack. And, once again, the attacks leave consumers, patients,…
House Ways and Means Committee Hearing on MACRA Implementation – Grave…
The House Ways and Means Subcommittee on Health held a hearing on the implementation of the Medicare Access & CHIP…